But how accurate will the results be? The COVID-19 breath test was used in a study of 2,409 patients, a group that included those with and without COVID-19 symptoms. The breathalyzer correctly identified 91% of positive samples and 99% of negative samples. Even so, the FDA says that all positive results from a breathalyzer test should be confirmed with a molecular test,
The F.D.A. authorized a breath-based test made by a small Texas company, which said it hoped that mobile sites could use the device.
New device looks for signature mix of volatile compounds in patients' exhaled air.
The main benefit for consumers are twofold: one, there’s no nose swab involved. Two, the tests were also found to be highly accurate.
Developed by a company in Texas called InspectIR that specializes in portable opioid- and cannabis-detection devices, its COVID-19 Breathalyzer will be used in places where tests are collected and analyzed, including doctor’s offices, hospitals, and mobile sites.
The breathalyzer can give back results in three minutes, but has to be performed by a health care professional.
Frisco-based InspectIR received the FDA emergency use authorization on Friday for its breathalyzer test, which tests for organic compounds associated with COVID-19 in a person's breath. According to a study, the tests are more effective than the rapid antigen tests available for free from the U.S. government.
A research, development & device company focused on portable COVID-19 diagnostic screening applications.